+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Critical Care Therapeutics - Global Market Trajectory & Analytics

  • ID: 5140868
  • Report
  • April 2021
  • Region: Global
  • 280 pages
  • Global Industry Analysts, Inc
Global Critical Care Therapeutics Market to Reach $3.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Critical Care Therapeutics estimated at US$2.9 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 2.6% over the analysis period 2020-2027. Albumin, one of the segments analyzed in the report, is projected to record a 3% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Prothrombin Complex Concentrates segment is readjusted to a revised 2.1% CAGR for the next 7-year period.



The U.S. Market is Estimated at $785.8 Million, While China is Forecast to Grow at 4.9% CAGR

The Critical Care Therapeutics market in the U.S. is estimated at US$785.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$700.3 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.6% and 1.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Antithrombin Concentrates Segment to Record 2.3% CAGR

In the global Antithrombin Concentrates segment, USA, Canada, Japan, China and Europe will drive the 1.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$260.9 Million in the year 2020 will reach a projected size of US$298 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$475 Million by the year 2027, while Latin America will expand at a 3.2% CAGR through the analysis period.

Select Competitors (Total 37 Featured):
  • Abeona Therapeutics Inc.
  • ADMA Biologics, Inc.
  • Albumedix Ltd.
  • Asklepios Biopharmaceutical, Inc.
  • Aspen Pharmacare Holdings Ltd.
  • Baxter International Inc.
  • Bayer Healthcare AG
  • Bio Products Laboratory Ltd.
  • BioDelivery Sciences International, Inc.
  • Biogen, Inc.
  • BioMarin Pharmaceutical Inc.
  • Biotest Pharmaceuticals Corporation
  • Bristol-Myers Squibb Company
  • Catalyst Biosciences, Inc.
  • China Biologic Products Holdings, Inc.
  • Cosmo Pharmaceuticals NV
  • CSL Behring
  • Grifols International SA
  • Kamada Ltd.
  • Kedrion Biopharma, Inc.
  • Medxbio Pte. Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novo Nordisk A/S
  • Novozymes A/S
  • Octapharma AG
  • Portola Pharmaceuticals, Inc.
  • ProMetic Life Sciences, Inc.
  • rEVO Biologics, Inc.
  • Rockwell Medical
  • Sanquin
  • Shanghai RAAS Blood Products Co., Ltd.
  • Shire PLC
  • Teva Pharmaceutical Industries Ltd.
  • The Medicines Company
  • Thermo Fisher Scientific, Inc.
  • Ventria Bioscience
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS

IV. COMPETITION
  • Total Companies Profiled: 37
Note: Product cover images may vary from those shown
Adroll
adroll